{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:11:08Z","timestamp":1782256268645,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1038\/sj.bjc.6602389","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T18:28:45Z","timestamp":1110306525000},"page":"857-866","source":"Crossref","is-referenced-by-count":32,"title":["Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families"],"prefix":"10.1038","volume":"92","author":[{"given":"H","family":"Jernstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"B\u00e5geman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,1]]},"reference":[{"key":"BF6602389_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0014-5793(03)00315-6","volume":"541","author":"S Abramovitcha","year":"2003","unstructured":"Abramovitcha S, Glasera T, Ouchib T, Werner H (2003) BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett 541: 149\u2013154","journal-title":"FEBS Lett"},{"key":"BF6602389_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"BF6602389_CR3","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1210\/jcem.87.6.8673","volume":"87","author":"N Arends","year":"2002","unstructured":"Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, Clark A (2002) Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 87: 2720\u20132724","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6602389_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1530\/acta.0.1240620","volume":"124","author":"P Bang","year":"1991","unstructured":"Bang P, Eriksson U, Sara V, Wivall IL, Hall K (1991) Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 124: 620\u2013629","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF6602389_CR5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/0140-6736(93)92469-A","volume":"341","author":"V Beral","year":"1993","unstructured":"Beral V, Reeves G (1993) Childbearing, oral contraceptive use, and breast cancer (letter) (see comments). Lancet 341: 1102","journal-title":"Lancet"},{"key":"BF6602389_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11912-001-0083-7","volume":"3","author":"NF Boyd","year":"2001","unstructured":"Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ (2001) Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 3: 314\u2013321","journal-title":"Curr Oncol Rep"},{"key":"BF6602389_CR7","first-page":"3744","volume":"60","author":"C Byrne","year":"2000","unstructured":"Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60: 3744\u20133748","journal-title":"Cancer Res"},{"key":"BF6602389_CR8","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53\u2009297 women with breast cancer and 100\u2009239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713\u20131727","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"BF6602389_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjc.6600728","volume":"88","author":"K DeLellis","year":"2003","unstructured":"DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii\/Los Angeles multiethnic cohort. Br J Cancer 88: 277\u2013282","journal-title":"Br J Cancer"},{"key":"BF6602389_CR10","first-page":"15","volume-title":"Diseases of the Breast","author":"R Dickson","year":"1996","unstructured":"Dickson R (1996) Biochemical control of breast development. In Diseases of the Breast Harris JR, Lippman ME, Morrow M, Hellman S (eds) pp 15\u201325. Philadelphia: Lippincott-Raven"},{"key":"BF6602389_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/oxfordjournals.aje.a114594","volume":"125","author":"WD Dupont","year":"1987","unstructured":"Dupont WD, Page DL (1987) Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125: 769\u2013779","journal-title":"Am J Epidemiol"},{"key":"BF6602389_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265\u2013271","journal-title":"Am J Hum Genet"},{"key":"BF6602389_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1008801131831","volume":"10","author":"KM Egan","year":"1999","unstructured":"Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Baron JA, Willett WC, Stampfer MJ, Trichopoulos D (1999) The relation of breast size to breast cancer risk in postmenopausal women (United States). Cancer Causes Control 10: 115\u2013118","journal-title":"Cancer Causes Control"},{"key":"BF6602389_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M and the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676\u2013689","journal-title":"Am J Hum Genet"},{"key":"BF6602389_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","volume":"3","author":"G Furstenberger","year":"2002","unstructured":"Furstenberger G, Senn HJ (2002) Insulin-like growth factors and cancer. Lancet Oncol 3: 298\u2013302","journal-title":"Lancet Oncol"},{"key":"BF6602389_CR16","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa021293","volume":"348","author":"AS Hamilton","year":"2003","unstructured":"Hamilton AS, Mack TM (2003) Puberty and genetic susceptibility to breast cancer in a case\u2013control study in twins. N Engl J Med 348: 2313\u20132322","journal-title":"N Engl J Med"},{"key":"BF6602389_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351: 1393\u20131396","journal-title":"Lancet"},{"key":"BF6602389_CR18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1172\/JCI119081","volume":"98","author":"M Harrela","year":"1996","unstructured":"Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98: 2612\u20132615","journal-title":"J Clin Invest"},{"key":"BF6602389_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/09513599809024960","volume":"12","author":"BW Hartmann","year":"1998","unstructured":"Hartmann BW, Laml T, Kirchengast S, Albrecht AE, Huber JC (1998) Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I. Gynecol Endocrinol 12: 123\u2013127","journal-title":"Gynecol Endocrinol"},{"key":"BF6602389_CR20","first-page":"862","volume":"11","author":"MD Holmes","year":"2002","unstructured":"Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11: 862\u2013867","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6602389_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1015766322258","volume":"7","author":"RC Hovey","year":"2002","unstructured":"Hovey RC, Trott JF, Vonderhaar BK (2002) Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 7: 17\u201338","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BF6602389_CR22","first-page":"1265","volume":"8","author":"H Jernstr\u00f6m","year":"1999","unstructured":"Jernstr\u00f6m H, Barrett-Connor E (1999) Obesity, weight change, fasting insulin, pro-insulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: The Rancho Bernardo Study. J Women's Health 8: 1265\u20131272","journal-title":"J Women's Health"},{"key":"BF6602389_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/mgme.2000.3130","volume":"72","author":"H Jernstr\u00f6m","year":"2001","unstructured":"Jernstr\u00f6m H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA (2001a) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for pre-menopausal breast cancer risk. Mol Genet Metab 72: 144\u2013154","journal-title":"Mol Genet Metab"},{"key":"BF6602389_CR24","first-page":"377","volume":"10","author":"H Jernstr\u00f6m","year":"2001","unstructured":"Jernstr\u00f6m H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M (2001b) Genetic and non-genetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10: 377\u2013384","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6602389_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0959-8049(97)10088-0","volume":"34","author":"H Jernstr\u00f6m","year":"1998","unstructured":"Jernstr\u00f6m H, Johannsson O, Borg \u00c5, Ivarsson H, Olsson H (1998) BRCA1-positive patients are small for gestational age compared with their unaffected relatives. Eur J Cancer 34: 368\u2013371","journal-title":"Eur J Cancer"},{"key":"BF6602389_CR26","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/S0140-6736(99)04336-6","volume":"354","author":"H Jernstr\u00f6m","year":"1999","unstructured":"Jernstr\u00f6m H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber M, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet J-S, Narod SA (1999) Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 354: 1846\u20131850","journal-title":"Lancet"},{"key":"BF6602389_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000292493","volume":"38","author":"H Jernstr\u00f6m","year":"1994","unstructured":"Jernstr\u00f6m H, Olsson H (1994) Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives. Gynecol Obstetr Invest 38: 261\u2013265","journal-title":"Gynecol Obstetr Invest"},{"key":"BF6602389_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/oxfordjournals.aje.a009153","volume":"145","author":"H Jernstr\u00f6m","year":"1997","unstructured":"Jernstr\u00f6m H, Olsson H (1997) Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19\u201325 years. Am J Epidemiol 145: 571\u2013580","journal-title":"Am J Epidemiol"},{"key":"BF6602389_CR29","first-page":"310","volume":"78","author":"PC Kao","year":"1994","unstructured":"Kao PC, Matheny Jr AP, Lang CA (1994) Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab 78: 310\u2013312","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6602389_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","volume":"195","author":"D LeRoith","year":"2003","unstructured":"LeRoith D, Roberts CTJ (2003) The insulin-like growth factor system and cancer. Cancer Lett 195: 127\u2013137","journal-title":"Cancer Lett"},{"key":"BF6602389_CR31","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2105\/AJPH.89.8.1244","volume":"89","author":"PM Marcus","year":"1999","unstructured":"Marcus PM, Baird DD, Millikan RC, Moorman PG, Qaqish B, Newman B (1999) Adolescent reproductive events and subsequent breast cancer risk. Am J Public Health 89: 1244\u20131247","journal-title":"Am J Public Health"},{"key":"BF6602389_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng0995-17","volume":"11","author":"ST Marquis","year":"1995","unstructured":"Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL, Chodoch LA (1995) The developmental pattern of Brca 1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11: 17\u201326","journal-title":"Nat Genet"},{"key":"BF6602389_CR33","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1074\/jbc.272.29.18132","volume":"272","author":"TL McCarthy","year":"1997","unstructured":"McCarthy TL, Ji C, Shu H, Casinghino S, Crothers K, Rotwein P, Centrella M (1997) 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures. J Biol Chem 272: 18132\u201318139","journal-title":"J Biol Chem"},{"key":"BF6602389_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ijc.10473","volume":"100","author":"SA Missmer","year":"2002","unstructured":"Missmer SA, Haiman CA, Hunterk DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN, Hankinson SE (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100: 332\u2013336","journal-title":"Int J Cancer"},{"key":"BF6602389_CR35","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","volume":"94","author":"SA Narod","year":"2002","unstructured":"Narod SA, Dube MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstr\u00f6m H, Sun P, Brunet JS (2002) Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 94: 1773\u20131779","journal-title":"J Natl Cancer Inst"},{"key":"BF6602389_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.neo.7900229","volume":"4","author":"JS Oh","year":"2002","unstructured":"Oh JS, Kucab JE, Bushel PR, Martin K, Bennett L, Collins J, DiAugustine RP, Barrett JC, Afshari CA, Dunn SE (2002) Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 4: 204\u2013217","journal-title":"Neoplasia"},{"key":"BF6602389_CR37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03000492","volume":"7","author":"H Olsson","year":"1990","unstructured":"Olsson H (1990) Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill? Med Oncol Tumor Pharmacother 7: 61\u201364","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"BF6602389_CR38","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/jnci\/81.13.1000","volume":"81","author":"H Olsson","year":"1989","unstructured":"Olsson H, M\u00f6ller T, Ranstam J (1989) Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst 81: 1000\u20131004","journal-title":"J Natl Cancer Inst"},{"key":"BF6602389_CR39","doi-asserted-by":"publisher","first-page":"13078","DOI":"10.1073\/pnas.93.23.13078","volume":"93","author":"JV Rajan","year":"1996","unstructured":"Rajan JV, Wang M, Marquis ST, Chodosh LA (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93: 13078\u201313083","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6602389_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/eje.0.1480171","volume":"148","author":"I Rietveld","year":"2003","unstructured":"Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM, Lamberts SW (2003) A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol 148: 171\u2013175","journal-title":"Eur J Endocrinol"},{"key":"BF6602389_CR41","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1210\/jcem.83.7.4964","volume":"83","author":"CJ Rosen","year":"1998","unstructured":"Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83: 2286\u20132290","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6602389_CR42","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/S0021-9258(19)89179-2","volume":"261","author":"P Rotwein","year":"1986","unstructured":"Rotwein P, Pollock KM, Didier DK, Krivi GG (1986) Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 261: 4828\u20134832","journal-title":"J Biol Chem"},{"key":"BF6602389_CR43","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","volume":"76","author":"CE Stewart","year":"1996","unstructured":"Stewart CE, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76: 1005\u20131026","journal-title":"Physiol Rev"},{"key":"BF6602389_CR44","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Streuwing","year":"1997","unstructured":"Streuwing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi jews. N Engl J Med 336: 1401\u20131408","journal-title":"N Engl J Med"},{"key":"BF6602389_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00008469-199612002-00006","volume":"5","author":"E Thurfjell","year":"1996","unstructured":"Thurfjell E, Hsieh CC, Lipworth L, Ekbom A, Adami HO, Trichopoulos D (1996) Breast size and mammographic pattern in relation to breast cancer risk. Eur J Cancer Prev 5: 37\u201341","journal-title":"Eur J Cancer Prev"},{"key":"BF6602389_CR46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jmg.32.12.982","volume":"32","author":"P Tonin","year":"1995","unstructured":"Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, Belanger D, Monte M, Narod SA (1995) A large multisite cancer family is linked to BRCA2. J Med Genet 32: 982\u2013984","journal-title":"J Med Genet"},{"key":"BF6602389_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/diabetes.50.3.637","volume":"50","author":"N Vaessen","year":"2001","unstructured":"Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50: 637\u2013642","journal-title":"Diabetes"},{"key":"BF6602389_CR48","first-page":"388","volume":"44","author":"JL Weber","year":"1989","unstructured":"Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388\u2013396","journal-title":"Am J Hum Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602389","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:14:32Z","timestamp":1684412072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["BF6602389"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602389","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}